MONKEYPOX (MPOX) DIAGNOSIS MARKET Challenges and Opportunities

The global monkeypox (Mpox) diagnosis market faces significant restraints due to high costs associated with advanced diagnostic tests. These expenses limit accessibility, particularly in low-resource settings, hindering timely diagnosis and treatment. Additionally, the complexity of these tests often requires specialized personnel and infrastructure, further escalating costs. As a result, many healthcare facilities may opt for less accurate, cost-effective alternatives, which can delay effective disease management and control efforts in affected regions.

Market Opportunity - Rising demand for rapid and accurate testing solutions

The global monkeypox (Mpox) diagnosis market is growing due to increasing outbreaks and the demand for rapid, accurate tests. Conventional methods are too slow, driving interest in rapid point-of-care tests using platforms like lateral flow assays, CRISPR, and portable polymerase chain reaction. Integrated devices for non-laboratory settings are also gaining popularity. Collaborations with research institutes and government funding are accelerating the development of advanced tests, fueling market growth and expected significant revenue increases in the coming years.